Peter Levins, MD
Family Medicine · Phoenix, AZNPI 1407876303
Payments from drug & device makers
Across 891 payments — averaging $1089.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$464K
- Kowa Research Institute, Inc.$255K
- Sanofi Pasteur Inc.$94K
- GSK$65K
- Akcea Therapeutics, Inc.$37K
- Sanofi US Services Inc.$31K
- plus $23K from 20 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 512 | $464,384 |
| Kowa Research Institute, Inc. | 75 | $255,432 |
| Sanofi Pasteur Inc. | 17 | $94,038 |
| GSK | 55 | $64,841 |
| Akcea Therapeutics, Inc. | 140 | $37,414 |
| Sanofi US Services Inc. | 11 | $31,432 |
| Regeneron | 10 | $21,059 |
| Lexicon Pharmaceuticals, Inc. | 1 | $958 |
| AstraZeneca | 15 | $259 |
| AbbVie(2 entities) | 8 | $150 |
| Amgen | 5 | $112 |
| Pfizer | 6 | $108 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $96 |
| Novo Nordisk | 7 | $94 |
| Astellas Pharma US Inc | 3 | $54 |
| Lilly USA, LLC | 4 | $48 |
| Sanofi-aventis U.S. LLC | 3 | $41 |
| Boehringer Ingelheim | 2 | $32 |
| Genentech USA, Inc. | 2 | $30 |
| Johnson & Johnson | 2 | $30 |
| Novartis | 2 | $28 |
| Indivior Inc. | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $15 |
| Merck | 1 | $12 |
| Medtronic | 1 | $12 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
How this compares
$970,708 in reported general payments places this provider in the 95th percentile of 2,099 family medicine providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Phoenix
- Brock MerrittPhoenix$8.4M
- Douglas CunninghamPhoenix$4.9M
- Jeffrey ZacherPhoenix$2M
- Trisha TavaresPhoenix$1.6M
- David FrancykPhoenix$1.3M
- James BeachPhoenix$1.2M
- Elysa ShawPhoenix$774K
- Mitchell EdelsteinPhoenix$741K
- Brian DedinskyPhoenix$589K
- Sylvia GutierrezPhoenix$356K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.